Expression of p25 impairs contextual learning but not latent inhibition in mice

NeuroReport

Volumn 17, Issue 18, 2006, Pages 1903-1905

  Mizuno, Keiko ^a   Plattner, Florian ^a   Peter Giese, K ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Cdk5; Contextual fear conditioning; Hippocampus; Latent inhibition; Memory; Mouse; Schizophrenia

Indexed keywords

PROTEIN P25;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; FEAR; FEMALE; HIPPOCAMPUS; LATENT INHIBITION; LEARNING DISORDER; LONG TERM POTENTIATION; MALE; MOUSE; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SEX DIFFERENCE; TRANSGENIC MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; ELECTROSHOCK; FEAR; GENE EXPRESSION; INHIBITION (PSYCHOLOGY); LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; SEX FACTORS;

EID: 33845764838     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328011c715     Document Type: Article

References (17)

1. Patrick GN, Zuckerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999; 402:615-622.
2. Giese KP, Ris L, Plattner F. Is there a role of the cylcin-dependent kinase 5 activator p25 in Alzheimer's disease? Neuroreport 2005; 16:1725-1730.
3. Swatton JE, Sellers LA, Faull RL, Holland A, Iritani S, Bahn S. Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain. Eur J Neurosci 2004; 19:2711-2719.
4. Tseng HC, Zhou Y, Shen Y, Tsai LH. A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. FEBS Lett 2002; 523:58-62.
5. Otth C, Concha II, Arendt T, Stieler J, Schliebs R, Gonzalez-Bilaut C. AbetaPP induces Cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J Alzheimer's Dis 2002; 4:417-430.
6. Angelo M, Plattner F, Irvine EE, Giese KP. Improved reversal learning and altered fear conditioning in transgenic mice with regionally restricted p25 expression. Eur J Neurosci 2003; 18:423-431.
7. Ris L, Angelo M, Plattner F, Capron B, Errington ML, Bliss TV, et al. Sexual dimorphisms in the effect of low-level p25 expression on synaptic plasticity and memory. Eur J Neurosci 2005; 21:3023-3033.
8. Fischer A, Sananbenesi F, Pang PT, Lu B, Tsai LH. Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 2005; 48:825-838.
9. Plattner F, Angelo M, Giese KP. The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J Biol Chem 2006; 281:25457-25465.
10. Phillips RG, LeDoux JE. Lesions of the dorsal hippocampal formation interfere with background but not foreground contextual fear conditioning. Learn Mem 1994; 1:34-44.
11. LaFerla FM, Kitazawa M. Antipodal effects of p25 on synaptic plasticity, learning, and memory: too much of a good thing is bad. Neuron 2005; 48:711-712.
12. Lubow RE. Latent inhibition and conditioned attention theory. Cambridge, London: Cambridge University Press; 1989.
13. Gray NS, Snowden RJ. The relevance of irrelevance in schizophrenia. Neurosci Biobehav Rev 2005; 29:989-999.
14. von Hertzen LSJ, Giese KP. Memory reconsolidation engages only a subset of immediate-early genes induced during consolidation. J Neurosci 2005; 25:1935-1942.
15. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 2003; 40:471-483.
16. Bliss TV, Collingridge GL, Laroche S. Neuroscience. ZAP and ZIP, a story to forget. Science 2006; 313:1058-1059.
17. Fioravanti M, Carlone O, Vitale B, Cinti ME, Clare L. A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia. Neuropsychol Rev 2005; 15:73-95.